EUVIMEDOpdag EUVIMED
Crossref

A‐to‐I RNA Edited miR‐3167 Restrains Malignant Behaviors of Lung Adenocarcinoma by Influencing SSR2‐Meditated Hippo Signaling

Dawei Qian, Dongsheng Zha, Yuanyao Sang, Jiangquan Tao, Bufeng Zhuang, Youshuang Cheng iD

Molecular Carcinogenesis · 2025

DOI: 10.1002/mc.70011 ↗

At a glance

Journal article in Molecular Carcinogenesis, 2025. Written by Dawei Qian and 5 co-authors. Institution: Department of Thoracic Surgery, Tongling Yi'an District People's Hospital, Tongling, Anhui, China. Major MEDLINE topics: MicroRNAs, Adenocarcinoma of Lung, Lung Neoplasms, Protein Serine-Threonine Kinases. Cited 2 times so far (Crossref); 33 references. Funded by: The authors received no specific funding for this work..

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Recently, RNA editing, as a natural modification process of RNA molecules, has aroused extensive interest in the scientific community. This study elaborated the role and process of A‐to‐I RNA edited miR‐3167 in lung adenocarcinoma (LUAD). RT‐qPCR and Western blot analysis were employed for the detection of miRNA and gene expressions. The function of miRNA was investigated through Transwell, CCK‐8 and flow cytometry assays. Dual‐luciferase reporter assay was conducted to assess the link between gene and miRNA. The level of A‐to‐I RNA editing for miR‐3167 was declined in LUAD tissues, which was linked to adverse clinical outcomes and prognosis in LUAD patients. In LUAD, ADAR2 enzyme is responsible for mediating the A‐to‐I RNA editing of miR‐3167. Functionally, LUAD cell viability and metastasis were scarcely influenced by wt‐miR‐3167, while miR‐3167 displayed antitumor activity in LUAD post A‐to‐I RNA editing. Mechanically, SSR2 is directly targeted by ed‐miR‐3167 in LUAD, but not wt‐miR‐3167. SSR2 served as a tumor promoter in LUAD progression by inactivating Hippo signaling and hindering immune infiltration. Ed‐miR‐3167 exerted tumor inhibitory effect in LUAD by weakening the carcinogenesis of SSR2. A‐to‐I RNA edited miR‐3167 curbs malignant behaviors of LUAD by activating Hippo signaling through downregulating SSR2, indicating that edited miR‐3167 has the potential as a therapeutic target for LUAD.

Subjects

MeSH terms (MEDLINE)

MicroRNAsAdenocarcinoma of LungLung NeoplasmsProtein Serine-Threonine KinasesRNA EditingRNA-Binding ProteinsHumansHippo Signaling PathwayGene Expression Regulation, NeoplasticSignal TransductionAnimalsCell ProliferationMiceCell Line, TumorPrognosisFemaleMaleCell Movement

Author keywords

A‐to‐I RNA editingHippo signalingSSR2lung adenocarcinomamiR‐3167

Substances

MicroRNAsProtein Serine-Threonine KinasesRNA-Binding Proteins

Authors and institutions

  • Department of Thoracic Surgery, Tongling Yi'an District People's Hospital, Tongling, Anhui, China.
  • Department of Thoracic Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University, Shanghai, China.

ORCID profiles: Youshuang Cheng

Funding

  • The authors received no specific funding for this work.

Cite

APA

Qian, D., Zha, D., Sang, Y., Tao, J., Zhuang, B., & Cheng, Y. (2025). A‐to‐I RNA Edited miR‐3167 Restrains Malignant Behaviors of Lung Adenocarcinoma by Influencing SSR2‐Meditated Hippo Signaling. Molecular Carcinogenesis. https://doi.org/10.1002/mc.70011

Vancouver

Qian D, Zha D, Sang Y, Tao J, Zhuang B, Cheng Y. A‐to‐I RNA Edited miR‐3167 Restrains Malignant Behaviors of Lung Adenocarcinoma by Influencing SSR2‐Meditated Hippo Signaling. Molecular Carcinogenesis. 2025. doi:10.1002/mc.70011

BibTeX
@article{Qian2025,
  author = {Qian, Dawei and Zha, Dongsheng and Sang, Yuanyao and Tao, Jiangquan and Zhuang, Bufeng and Cheng, Youshuang},
  title = {A‐to‐I RNA Edited miR‐3167 Restrains Malignant Behaviors of Lung Adenocarcinoma by Influencing SSR2‐Meditated Hippo Signaling},
  journal = {Molecular Carcinogenesis},
  year = {2025},
  doi = {10.1002/mc.70011}
}
Start for free →